Assignee
XALUD THERAPEUTICS INC
US·2 granted patents·7 pending applications·0 citations·filing 2014–2024
Top patents by PatentIndex Score
9 records- 0169US2023158114A1Methods for the treatment of inflammatory joint diseaseXALUD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0267US2022313785A1Methods for the treatment of inflammatory joint diseaseXALUD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0366US2024352089A1Methods and compositions to enhance the anti-inflammatory effects of interleukin 10XALUD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0460US2020093892A1Methods for the treatment of inflammatory joint diseaseXALUD THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0560US2023203053A1Halogenated derivatives of morphinans and uses thereofXALUD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0659US2025051412A1Dosing regimen for il-10 encoding expression constructXALUD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0756US11505556B2Halogenated derivatives of morphinans and uses thereofXALUD THERAPEUTICS INC·Filed 2018·Granted Nov 22, 2022·0 cites·21 claims
- 0854US10512672B2Methods for the treatment of inflammatory joint diseaseXALUD THERAPEUTICS INC·Filed 2014·Granted Dec 24, 2019·0 cites·36 claims
- 0938US2019112354A1Methods and compositions to enhance the anti-inflammatory effects of interleukin 10XALUD THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →